| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 107 | 1,050 | 560 | $80 | $266.8K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 364 | 880 | 400 | $60 | $136K |
| 99393 | The provider performs an established well–patient visit for a child who is between the ages of 5 and 11. | 121 | 190 | 180 | $110 | $94.2K |
| 90460 | In this procedure, the provider administers a single live attenuated vaccine through a parenteral, oral, intranasal, intramuscular, or intravenous to a patient up to 18 years of age. | 45 | 120 | 550 | $30 | $73K |
| 99394 | The provider performs an established well–patient visit for an adolescent who is between the ages of 12 and 17. | 91 | 200 | 130 | $130 | $58.6K |
| 99212 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a straightforward level of medical decision making,… | 87 | 340 | 100 | $100 | $43.3K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 92 | 170 | 70 | $90 | $43.2K |
| 99203 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the provider… | 67 | 240 | 70 | $70 | $37.1K |
| 90471 | In this procedure, the provider administers a live attenuated vaccine using a percutaneous, intradermal, subcutaneous, or intramuscular route. | 313 | 320 | 290 | $20 | $28K |
| 87635 | Using an amplified nucleic acid probe technique, the lab analyst performs the necessary steps to identify the nucleic acids from the severe acute respiratory syndrome coronavirus 2 (SARS–COV–2) virus… | 103 | 140 | 90 | $30 | $13.1K |